Show
Sort by
-
Tofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgium cohort study
-
eTofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgian cohort study
-
Lanreotide autogel in the treatment of idiopathic refractory diarrhea : results of an exploratory, controlled, before and after, open-label, multicenter, prospective clinical trial
-
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
-
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
-
Mucosal healing predicts sustained clinical remission in early Crohn's disease
-
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
-
Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis
-
Maintenance therapy for ulcerative colitis has no imact on changes in the extent fo ulcerative colitis. On behalf of the Belgian IBD Research Group
-
A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies
-
Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study
-
Raltitrexed/gemcitabine in patients with advanced biliary tract adenocarcinoma: a phase II study